PRNAF: Alterity Therapeutics Limited Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 17.02
Enterprise Value ($M) n/a
Book Value ($M) 7.79
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 7.67
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -2.52
Return on Assets (ROA) -0.89
Return on Equity (ROE) -1.12

Liquidity (mrq)
Quick Ratio 3.84
Current Ratio 3.84

Balance Sheet (mrq) ($M)
Current Assets 10.43
Assets 10.55
Liabilities 2.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.75
Operating Income -19.88
Net Income -19.12

Cash Flow Statement (mra) ($M)
Cash From Operations -12.61
Cash from Investing -0.01
Cash from Financing 9.22

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
PLPL – Plandaí Biotechnology, Inc. PPCB – Propanc Biopharma, Inc.
PREDQ – Predictive Technology Group, Inc. PROCF – Procaps Group S.A.
PRRUF – Immutep Limited


Financial data and stock pages provided by
Fintel.io